Banff classification and progress on liver allograft pathology

Guo Hui; Wang Zhenglu; Cong Wenming; Chen Zhishui

doi:10.3969/j.issn.1674-7445.2021.05.003

Volume 12 Issue 5

Sep. 2021

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2021 > 12(5): 512-524

Guo Hui, Wang Zhenglu, Cong Wenming, et al. Banff classification and progress on liver allograft pathology[J]. ORGAN TRANSPLANTATION, 2021, 12(5): 512-524. doi: 10.3969/j.issn.1674-7445.2021.05.003

Citation:

Guo Hui, Wang Zhenglu, Cong Wenming, et al. Banff classification and progress on liver allograft pathology[J]. ORGAN TRANSPLANTATION, 2021, 12(5): 512-524. doi: 10.3969/j.issn.1674-7445.2021.05.003

Citation:

Guo Hui, Wang Zhenglu, Cong Wenming, et al. Banff classification and progress on liver allograft pathology[J]. ORGAN TRANSPLANTATION, 2021, 12(5): 512-524. doi: 10.3969/j.issn.1674-7445.2021.05.003

PDF( 12553 KB)

Banff classification and progress on liver allograft pathology

doi: 10.3969/j.issn.1674-7445.2021.05.003

Organ Transplantation Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation of Ministry of Education, Key Laboratory of Organ Transplantation of National Health Commission of China, Key Laboratory of Organ Transplantation of Chinese Academy of Medical Sciences, Wuhan 430030, China

More Information

Corresponding author: Chen Zhishui, E-mail: zschen@tjh.tjmu.edu.cn
Received Date: 2021-07-09
Available Online: 2021-09-15
Publish Date: 2021-09-15

Abstract

Abstract

The pathology of liver allograft biopsy is not only essential for the evaluation of liver donor, but also for the diagnosis and differential diagnosis of posttransplantation complications. With the development of liver transplantation in clinical practice, relevant studies of the pathological diagnosis of liver allograft complications have been deepened. Banff classification on liver allograft pathology have been gradually established within the international community. In China, pathological studies related to liver allograft pathology have been steadily carried out, and the pathological diagnostic basis of liver allograft pathology suitable for the clinical practice of liver transplantation in China has been gradually formed. This article reviews the history of Banff liver allograft pathology and major pathological lesions of liver allograft complications, aiming to provide reference for implementing pathological diagnosis of liver allograft pathology in China, assisting clinical diagnosis and targeted treatment of complications after liver transplantation, and further improving the survival of liver allograft and recipients.

FullText(HTML)

References(28)

References

[1]	Banff schema for grading liver allograft rejection: an international consensus document[J]. Hepatology, 1997, 25(3): 658-663. DOI: 10.1002/hep.510250328.
[2]	DEMETRIS A, ADAMS D, BELLAMY C, et al. Update of the International Banff Schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. an international panel[J]. Hepatology, 2000, 31(3): 792-799. DOI: 10.1002/hep.510310337.
[3]	郭晖. 移植肾抗体介导的排斥反应的病理学[J]. 器官移植, 2021, 12(3): 262-271. DOI: 10.3969/j.issn.1674-7445.2021.03.003. GUO H. Pathology of antibody-mediated rejection in renal allograft[J]. Organ Transplant, 2021, 12(3): 262-271. DOI: 10.3969/j.issn.1674-7445.2021.03.003.
[4]	MENGEL M, SIS B, HAAS M, et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection[J]. Am J Transplant, 2012, 12(3): 563-570. DOI: 10.1111/j.1600-6143.2011.03926.x.
[5]	HAAS M, SIS B, RACUSEN LC, et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions[J]. Am J Transplant, 2014, 14(2): 272-283. DOI: 10.1111/ajt.12590.
[6]	DEMETRIS AJ, BELLAMY C, HÜBSCHER SG, et al. 2016 Comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection[J]. Am J Transplant, 2016, 16(10): 2816-2835. DOI: 10.1111/ajt.13909.
[7]	中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 中国抗癌协会肝癌专业委员会病理学组, 等. 肝移植常见并发症病理诊断指南(2016版)[J]. 中华器官移植杂志, 2016, 37(8): 494-501. DOI: 10.3760/cma.j.issn.0254-1785.2016.08.010. Branch of Organ Transplantation of Chinese Medical Association, Branch of Organ Transplant Physician of Chinese Medical Doctor Association, Pathological Group of Chinese Society of Liver Cancer of Chinese Anti-cancer Association, et al. Guideline for the pathological diagnosis of common complications after liver transplantation (2016 edition)[J]. Chin J Organ Transplant, 2016, 37(8): 494-501. DOI:10.3760/cma.j.issn. 0254-1785.2016.08.010.
[8]	中华医学会器官移植学分会. 器官移植病理学临床技术操作规范(2019版)——肝移植[J]. 器官移植, 2019, 10(3): 267-277. DOI: 10.3969/j.issn.1674-7445.2019.03.008. Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification for pathology of organ transplantation (2019 edition): liver transplantation[J]. Organ Transplant, 2019, 10(3): 267-277. DOI: 10.3969/j.issn.1674-7445.2019.03.008.
[9]	JIMÉNEZ-CASTRO MB, CASILLAS-RAMÍREZ A, NEGRETE-SÁNCHEZ E, et al. Adipocytokines in steatotic liver surgery/transplantation[J]. Transplantation, 2019, 103(1): 71-77. DOI: 10.1097/TP.0000000000002098.
[10]	ÁLVAREZ-MERCADO AI, GULFO J, ROMERO GÓMEZ M, et al. Use of steatotic grafts in liver transplantation: current status[J]. Liver Transpl, 2019, 25(5): 771-786. DOI: 10.1002/lt.25430.
[11]	BABA HA, THEURER S, CANBAY A, et al. Liver transplantation. current aspects of pretransplantation diagnosis and rejection[J]. Pathologe, 2020, 41(5): 505-514. DOI: 10.1007/s00292-020-00813-9.
[12]	KOO J, WANG HL. Acute, chronic, and humoral rejection: pathologic features under current immunosuppressive regimes[J]. Surg Pathol Clin, 2018, 11(2): 431-452. DOI: 10.1016/j.path.2018.02.011.
[13]	KIM PT, DEMETRIS AJ, O'LEARY JG. Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'[J]. Curr Opin Organ Transplant, 2016, 21(2): 209-218. DOI: 10.1097/MOT.0000000000000275.
[14]	MILLER CM, DURAND F, HEIMBACH JK, et al. The international liver transplant society guideline on living liver donation[J]. Transplantation, 2016, 100(6): 1238-1243. DOI: 10.1097/TP.0000000000001247.
[15]	O'LEARY JG, CAI J, FREEMAN R, et al. Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts[J]. Am J Transplant, 2016, 16(2): 603-614. DOI: 10.1111/ajt.13476.
[16]	KOZLOWSKI T, ANDREONI K, SCHMITZ J, et al. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts[J]. Liver Transpl, 2012, 18(6): 641-658. DOI: 10.1002/lt.23403.
[17]	ALI S, ORMSBY A, SHAH V, et al. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection[J]. Transpl Immunol, 2012, 26(1): 62-69. DOI: 10.1016/j.trim.2011.08.005.
[18]	BOEVA I, KARAGYOZOV PI, TISHKOV I. Post-liver transplant biliary complications: current knowledge and therapeutic advances[J]. World J Hepatol, 2021, 13(1): 66-79. DOI: 10.4254/wjh.v13.i1.66.
[19]	MAGRO B, TACELLI M, MAZZOLA A, et al. Biliary complications after liver transplantation: current perspectives and future strategies[J]. Hepatobiliary Surg Nutr, 2021, 10(1): 76-92. DOI: 10.21037/hbsn.2019.09.01.
[20]	GERMANI G, BATTISTELLA S, ULINICI D, et al. Drug induced liver injury: from pathogenesis to liver transplantation[J]. Minerva Gastroenterol (Torino), 2021, 67(1): 50-64. DOI: 10.23736/S1121-421X.20.02795-6.
[21]	DEVARBHAVI H, AITHAL G, TREEPRASERTSUK S, et al. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines[J]. Hepatol Int, 2021, 15(2): 258-282. DOI: 10.1007/s12072-021-10144-3.
[22]	JIMÉNEZ-PÉREZ M, GONZÁLEZ-GRANDE R, GARCÍA-CORTÉS M, et al. Drug-induced liver injuryafter liver transplantation[J]. Liver Transpl, 2020, 26(9): 1167-1176. DOI: 10.1002/lt.25804.
[23]	中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J/CD]. 中国肝脏病杂志(电子版), 2019, 11(4): 5-27. DOI: 10.3969/j.issn.1674-7380.2019.04.002. Branch of Infectious Diseases of Chinese Medical Association, Branch of Hepatology of Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B: a 2019 update[J/CD]. Chin J Liver Dis(Electr Vers), 2019, 11(4): 5-27. DOI: 10.3969/j.issn.1674-7380.2019.04.002.
[24]	WANG Q, HUANG A, WANG JB, et al. Chronic drug-induced liver injury: updates and future challenges[J]. Front Pharmacol, 2021, 12: 627133. DOI: 10.3389/fphar.2021.627133.
[25]	KERKAR N, YANNI G. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: a comprehensive review[J]. J Autoimmun, 2016, 66: 17-24. DOI: 10.1016/j.jaut.2015.08.017.
[26]	BEER A, DIENES HP. Autoimmune hepatitis-is histology conclusive?[J]. Ann Transl Med, 2021, 9(8): 733. DOI: 10.21037/atm-20-5084.
[27]	MIYAGAWA-HAYASHINO A, HAGA H, EGAWA H, et al. Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome[J]. Transpl Int, 2009, 22(3): 303-312. DOI: 10.1111/j.1432-2277.2008.00803.x.
[28]	SWERDLOW SH, CAMPO E, PILERI SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20): 2375-2390. DOI: 10.1182/blood-2016-01-643569.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(10) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (1492) PDF downloads(311)

Banff classification and progress on liver allograft pathology

doi: 10.3969/j.issn.1674-7445.2021.05.003

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Banff classification and progress on liver allograft pathology

doi: 10.3969/j.issn.1674-7445.2021.05.003

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content